{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:48:05Z","timestamp":1793198885039,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Hospital","doi-asserted-by":"publisher","award":["CMRPG8G0581"],"award-info":[{"award-number":["CMRPG8G0581"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"name":"An Nan Hospital","award":["ANHRF103-10"],"award-info":[{"award-number":["ANHRF103-10"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.urolonc.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:54:48Z","timestamp":1547679288000},"page":"299.e7-299.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder"],"prefix":"10.1016","volume":"37","author":[{"given":"Ying-En","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peir-In","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yow-Ling","family":"Shiue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.01.001_bib0001","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/bjc.1986.65","article-title":"A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan","volume":"53","author":"Chen","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/009841098158322","article-title":"Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement","volume":"55","author":"Tsai","year":"1998","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk","volume":"102","author":"Lai","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/oem.2009.050195","article-title":"Bladder cancer among hairdressers: a meta-analysis","volume":"67","author":"Harling","year":"2010","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0006","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/oem.58.9.590","article-title":"Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands","volume":"58","author":"Zeegers","year":"2001","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature11706","article-title":"How cancer metabolism is tuned for proliferation and vulnerable to disruption","volume":"491","author":"Schulze","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1432-1327.1998.2510504.x","article-title":"Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages","volume":"251","author":"Renkema","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0011","first-page":"172","article-title":"Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer","volume":"53","author":"Johansen","year":"2006","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0012","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.18632\/oncotarget.14280","article-title":"Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients","volume":"8","author":"Wan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0013","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13046-018-0876-2","article-title":"Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through beta-catenin\/Erk\/Akt signaling in gastric cancer","volume":"37","author":"Geng","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12885-015-1592-3","article-title":"YKL-40 regulated epithelial-mesenchymal transition and migration\/invasion enhancement in non-small cell lung cancer","volume":"15","author":"Jefri","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1530\/ERC-14-0267","article-title":"Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells","volume":"21","author":"Jeet","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0016","doi-asserted-by":"crossref","first-page":"39740","DOI":"10.18632\/oncotarget.5469","article-title":"Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma","volume":"6","author":"Chiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MPA.0000000000000751","article-title":"Overexpression of YKL-40 predicts poor prognosis in patients undergoing curative resection of pancreatic cancer","volume":"46","author":"Chen","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0018","doi-asserted-by":"crossref","first-page":"12131","DOI":"10.1007\/s13277-014-2518-4","article-title":"Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0019","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/CBM-160255","article-title":"CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma","volume":"18","author":"Luo","year":"2017","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13000-016-0492-4","article-title":"High CHI3L1 expression is associated with glioma patient survival","volume":"11","author":"Steponaitis","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0021","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1007\/s13277-016-4838-z","article-title":"YKL-40\/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma","volume":"37","author":"Thongsom","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13277-014-2690-6","article-title":"Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0023","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.urolonc.2014.02.004","article-title":"Prognostic effect of serum and tissue YKL-40 levels in bladder cancer","volume":"32","author":"Tschirdewahn","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0024","doi-asserted-by":"crossref","first-page":"257.e19","DOI":"10.1016\/j.urolonc.2016.02.003","article-title":"Diagnostic potential of YKL-40 in bladder cancer","volume":"34","author":"Yasar","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0025","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskjot","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0026","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.25466","article-title":"CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells","volume":"128","author":"Ku","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0027","doi-asserted-by":"crossref","first-page":"39893","DOI":"10.1074\/jbc.M111.257451","article-title":"A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40","volume":"286","author":"Singh","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0028","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0029","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0031","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0032","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-04-1853","article-title":"Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1\/epidermal growth factor paracrine loop","volume":"65","author":"Goswami","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0033","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2119\/molmed.2011.00217","article-title":"Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling","volume":"18","author":"Coniglio","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0034","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0035","first-page":"18","article-title":"Macrophage phenotypes regulate scar formation and chronic wound healing","author":"Hesketh","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0036","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0037","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/jcp.24260","article-title":"Tumor associated macrophages and neutrophils in tumor progression","volume":"228","author":"Galdiero","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0038","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0039","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/onc.2011.498","article-title":"Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer","volume":"31","author":"Kawada","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0040","doi-asserted-by":"crossref","first-page":"15332","DOI":"10.1074\/jbc.M110.212514","article-title":"Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma","volume":"286","author":"Francescone","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0041","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a secreted glycoprotein, promotes tumor angiogenesis","volume":"28","author":"Shao","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0042","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","article-title":"Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications","volume":"18","author":"Kirschmann","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0043","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9440(10)64739-6","article-title":"Vasculogenic mimicry and tumor angiogenesis","volume":"156","author":"Folberg","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0044","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pathol.2017.09.015","article-title":"Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer","volume":"50","author":"Ngernyuang","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0046","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-10-0868","article-title":"A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers","volume":"10","author":"Faibish","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0047","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/carcin\/bgt380","article-title":"Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma","volume":"35","author":"Shao","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2019.01.001_bib0048","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/or.2014.3195","article-title":"YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line","volume":"32","author":"Akiyama","year":"2014","journal-title":"Oncol Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:15:31Z","timestamp":1761041731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1078143919300018"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.01.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}